Monopar Therapeutics (MNPR)

Last Year

19-May-23 -- 18-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

8

0

4

+1

0

+2

0

+3

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-Jan-24 7:38 PM View:	31-Dec-23 Option Exercise 0	Klausner Arthur J Director		Monopar Therapeutics - MNPR	0% 3.08M to 3.09M	0	0	--	--	Show Txns Hide Txns

03-Jan-24 7:37 PM View:	31-Dec-23 Option Exercise 0	Starr Christopher M Director		Monopar Therapeutics - MNPR	11% 67.66K to 75.26K	0	0	--	--	Show Txns Hide Txns

03-Jan-24 7:40 PM View:	31-Dec-23 Option Exercise 0	Anderson Raymond Director		Monopar Therapeutics - MNPR	39% 19.26K to 26.86K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 8:33 PM View:	31-Mar-24 Payment of Exercise ($4.88K)	Robinson Chandler Chief Executive Officer Director		Monopar Therapeutics - MNPR	2% 4.36M to 4.44M	0	0	--	--	Show Txns Hide Txns

03-Jan-24 7:40 PM View:	31-Dec-23 Option Exercise 0	Brown Michael J Director		Monopar Therapeutics - MNPR	0% 4.51M to 4.51M	0	0	--	--	Show Txns Hide Txns

02-Apr-24 8:35 PM View:	31-Mar-24 Payment of Exercise ($2.11K)	Cittadine Andrew Chief Operating Officer		Monopar Therapeutics - MNPR	93% 29.8K to 57.62K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 8:33 PM View:	31-Mar-24 Payment of Exercise ($2.78K)	Tsuchimoto Kim R Chief Financial Officer Director		Monopar Therapeutics - MNPR	132% 21.73K to 50.47K	0	0	--	--	Show Txns Hide Txns